PubMed Scraper

Scrape PubMed articles by search, filtered search link or PMID: titles, full abstracts, authors with affiliations and ORCID iDs, journal details, DOIs, MeSH terms, keywords, publication types, grants and free full-text links. Clean JSON, no login, no API key, no proxy.

Publisher description, verbatim
Last 7 dayson this actor
  • 1new actor
  • 14new rivals on PubMed
Each one reaches followers by email the morning after.Follow this actor
Key figures0 readings
Price / 1k$4.50per 1,000 results
Users / 30d1not enough history for a trend
Users, all time2not enough history for a trend
Runs / 30d0not enough history for a trend
Runs / user / mo—runs per monthly user
Standing
#16of 98

on PubMed, by users in the last 30 days among actors classified to this platform.

Recorded changes
  • 2026-10-27changeListed—on record
showing 1 of 1 in the last 30 days · followers get the next one by email

Alternatives on PubMed

The actors either side of #16 of 98, ranked by users in the last 30 days. Same platform, adjacent adoption — the comparable set.

all 98 on PubMed →
Sort
#ActorGradePrice / 1kUsers /30dSuccessRatingAgeFresh
11—RES$10.00 /1khigh price23 total——6maging
12—RES$50.00 /1ksteep price210 total——7mfresh
13—RES$2.00 /1kfair price23 total——3mfresh
14—EVT$6.00 /1k paper-matched12 total——16dfresh
15—RES$1.00 /1kgood price12 total——53daging
16—RES$4.50 /1khigh price12 total——14dfreshThis
17—RES$0.50 /1kgood price12 total——8dfresh
18—EVT$1.00 /1k article-scraped12 total——3maging
19—RES$3.00 /1kfair price12 total——48daging
20—EVT$2.00 /1k article12 total——2dfresh
21—RES$1.50 /1kgood price12 total——4dfresh

Follow this actor, compare it against its rivals, and get every overnight change in one morning report.

Publish it yourself? Claim your publisher page and its full history is yours free, forever.

Open in the app Claim this page

Numbers on this page are measured only by an independent census of the Apify Store — not self-reported. Not indexed: too little has happened to this actor for us to have anything worth saying yet.